Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 34, 2021 - Issue 23
Submit an article Journal homepage
332
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Toward rational management of patent ductus arteriosus: ductal disease staging and first line paracetamol

Arvind Sehgala Monash Newborn, Monash Children’s Hospital, Clayton, Australia;b Department of Pediatrics, Monash University, Melbourne, Australia
,
Itamar Nitzana Monash Newborn, Monash Children’s Hospital, Clayton, Australia
,
Mohan B. Krishnamurthya Monash Newborn, Monash Children’s Hospital, Clayton, Australia
,
Pramod Pharandea Monash Newborn, Monash Children’s Hospital, Clayton, Australia;b Department of Pediatrics, Monash University, Melbourne, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3251-1417
ORCID Icon &
Kenneth Tana Monash Newborn, Monash Children’s Hospital, Clayton, Australia;b Department of Pediatrics, Monash University, Melbourne, Australia
Pages 3940-3945 | Received 03 Jul 2019, Accepted 06 Dec 2019, Published online: 29 Dec 2019

References

  • Laughon M, Bose C, Clark R. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. J Perinatol. 2007;27(3):164–170.
  • McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007;92(6):F424–F427.
  • Sehgal A, McNamara PJ. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr. 2009;168(8):907–914.
  • Sehgal A, Paul E, Menahem S. Functional echocardiography in staging for ductal disease severity: role in predicting outcomes. Eur J Pediatr. 2013;172(2):179–184.
  • El-Khuffash A, James AT, Corcoran JD, et al. A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr. 2015;167(6):1354–1361.e2.
  • Pharande P, Watson H, Tan K, et al. Oral paracetamol for patent ductus arteriosus rescue closure. Pediatr Cardiol. 2018;39(1):183–190.
  • van Laere D, van Overmeire B, Gupta S, et al. Application of NPE in the assessment of a patent ductus arteriosus. Pediatr Res. 2018;84(S1):46–56.
  • Shepherd JL, Noori S. What is a hemodynamically significant PDA in preterm infants? Congenit Heart Dis. 2019;14(1):21–26.
  • Mashally S, Nield LE, McNamara PJ, et al. Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus. J Thorac Cardiovasc Surg. 2018;156(5):1937–1944.
  • Jasani B, Weisz DE, McNamara PJ. Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants. Semin Perinatol. 2018;42(4):243–252.
  • Bixler GM, Powers GC, Clark RH, et al. Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in United States neonatal intensive care units. J Pediatr. 2017;189:105–112.
  • Zonnenberg I, de Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr. 2012;101(3):247–251.
  • Kluckow M, Jeffery M, Gill A, et al. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F99–F104.
  • de Freitas Martins F, Ibarra Rios D, F Resende MH, et al. Relationship of patent ductus arteriosus size to echocardiographic markers of shunt volume. J Pediatr. 2018;202:50–55.e3.
  • Bin-Nun A, Fink D, Mimouni FB, et al. Paracetamol serum concentrations in neonates treated enterally for ductal closure: a pilot study. J Pediatr. 2018;198:304–307. [pii: S0022-3476(18)30048-9].
  • Härkin P, Härmä A, Aikio O, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. J Pediatr. 2016;177:72–77.e2.
  • Benitz WE, Bhombal S. The use of non-steroidal anti-inflammatory drugs for patent ductus arteriosus closure in preterm infants. Semin Fetal Neonat Med. 2017;22(5):302–307.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.